JANSSEN ALZHEIMER IMMUNOTHERAPY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 35220
 
  
 
C07K PEPTIDES 14122
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 491
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS147
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8916165 Humanized Aβ antibodies for use in improving cognitionDec 15, 05Dec 23, 14[A61K, C07K]
8642044 Prevention and treatment of amyloidogenic diseaseAug 20, 07Feb 04, 14[A61K]
8535673 Prevention and treatment of amyloidogenic diseaseAug 20, 04Sep 17, 13[A61K]
8440799 Methods of purifying anti A β antibodiesOct 12, 10May 14, 13[C07K]
8357781 Neuroactive fragments of APPJun 01, 07Jan 22, 13[C12P, C07K]
8318164 Anti A beta antibody formulationDec 14, 09Nov 27, 12[A61K]
8128928 Humanized antibodies that recognize beta amyloid peptideAug 13, 07Mar 06, 12[A61K]
8034339 Prevention and treatment of amyloidogenic diseaseAug 20, 04Oct 11, 11[A61K]
8034348 Prevention and treatment of amyloidogenic diseaseAug 20, 07Oct 11, 11[A61K]
7964192 Prevention and treatment of amyloidgenic diseaseMay 28, 99Jun 21, 11[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0227,274 Prevention and Treatment of Amyloidogenic DiseaseAbandonedSep 03, 13Aug 14, 14[C07K]
2013/0273,574 OLIGOMERIC A-BETA IN THE DIAGNOSIS, PROGNOSIS, AND MONITORING OF ALZHEIMER'S DISEASEAbandonedMar 13, 13Oct 17, 13[G01N]
2013/0084,245 PET MONITORING OF A-BETA-DIRECTED IMMUNOTHERAPYAbandonedFeb 25, 11Apr 04, 13[A61K]
2013/0058,869 Prevention And Treatment Of Amyloidogenic DiseaseAbandonedOct 10, 11Mar 07, 13[A61K, A61P]
2012/0282,248 PREVENTION AND TREATMENT OF CEREBRAL AMYLOID ANGIOPATHYAbandonedMar 30, 11Nov 08, 12[A61K, A61P]
2012/0276,116 Prevention and Treatment of Amyloidogenic DiseaseAbandonedOct 11, 11Nov 01, 12[A61K, A61P]
2012/0070,379 IMMUNOTHERAPY REGIMES DEPENDENT ON APOE STATUSAbandonedSep 13, 11Mar 22, 12[A61K, G06Q, A61P]
2011/0306,756 Prevention and Treatment of Amyloidogenic DiseaseAbandonedDec 22, 10Dec 15, 11[C07K]
2011/0135,660 PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC DISEASEAbandonedMar 23, 10Jun 09, 11[A61K, A61P]
2010/0031,377 Prevention and treatment of synucleinopathic and amyloidogenic diseaseAbandonedAug 09, 05Feb 04, 10[A61K, C12N, A61P, C07K]
2009/0297,511 PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASEAbandonedDec 04, 08Dec 03, 09[A61K, C07H, C12P, C12N, C07K]
2009/0285,806 Methods and compositions for improving recombinant protein productionAbandonedOct 05, 05Nov 19, 09[A61K, C12Q, C12P, C12N, C07K]
2009/0155,256 Immunotherapy Regimes Dependent On APOE StatusAbandonedOct 17, 08Jun 18, 09[A61K, C07H, A61P, C07K]
2008/0299,074 A-BETA IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAMEAbandonedAug 20, 07Dec 04, 08[A61K]
2008/0292,625 PREVENTION AND TREATMENT OF CEREBRAL AMYLOID ANGIOPATHYAbandonedApr 18, 08Nov 27, 08[A61K, A61P, C07K]
2008/0279,873 ACTIVE IMMUNIZATION TO GENERATE ANTIBODIES TO SOLUBLE A-BETAAbandonedFeb 25, 08Nov 13, 08[A61K, A61P]
2008/0281,082 HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDEAbandonedAug 20, 07Nov 13, 08[C07K]
2008/0227,719 PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASEAbandonedAug 20, 07Sep 18, 08[A61K, A61P]
2008/0096,818 PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASEAbandonedAug 20, 07Apr 24, 08[A61K, A61P]
2008/0050,367 Humanized antibodies that recognize beta amyloid peptideAbandonedSep 05, 06Feb 28, 08[A61K, C12N, A61P, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.